Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Meeting of the Board of Directors ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma Ltd has informed BSE that its Board of Directors will meet on Friday, 30 May 2025 at 4:00 PM. The main agenda is to consider and approve the audited financial results for the quarter and financial year ended 31 March 2025. The company also announced a trading window closure with immediate effect, which will remain in place until 48 hours after the public announcement of the audited results. No financial figures or specific business decisions have been disclosed in this intimation.
This is a routine procedural filing ahead of the FY25 results announcement. Shareholders should await the actual audited numbers on or after 30 May 2025 to gauge company performance. Insiders are restricted from trading until 48 hours after the results are published.